Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-guided abbreviated DAPT vs unguided de-escalation in ACS with high bleeding risk
KCT0010185Phase 3Not yet recruiting
- Sponsor
- Dong-A ST
- Start
- Mar 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin + P2Y12 antagonist in myocardial infarction (MI), unstable angina, sponsored by Dong-A ST. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
aspirin + P2Y12 antagonist
03
Conditions
myocardial infarction (MI)unstable angina
Beyond the preview
Go deeper on KCT0010185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010185.